USPTO serial 90644564
REFLECTIONBIO -BY PATIENTS, FOR PATIENTS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 16, 2023
- Examiner
- FRENCH, CURTIS W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with REFLECTIONBIO -BY PATIENTS, FOR PATIENTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
REFLECTION BIOTECHNOLOGIES LIMITED
New Territories, HK
Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
REFLECTION BIOTECHNOLOGIES LIMITED
New Territories, HK
Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
REFLECTION BIOTECHNOLOGIES LIMITED
New Territories, HK
Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kerrijane John
Kerrijane John FISH & RICHARDSON P.C.P.O. BOX 1022MINNEAPOLIS, MN 55440-1022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, medical and veterinary preparations for genetically based diseases, rare diseases, and ocular diseases; sanitary preparations for medical purposes; dietetic food and substances, in the nature of sugar adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; medicines for human purposes for the treatment of genetically based diseases, rare diseases, and ocular diseases; pharmaceuticals for genetically based diseases, rare diseases, ocular diseases; pharmaceutical preparations for use in the treatment of genetically based diseases, rare diseases, and ocular diseases; pharmaceutical preparations for orphan drugs, gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical, dental or veterinary use in the fields of genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; artificial limbs, eyes and teeth; orthopedic devices for diagnostic and therapeutic use in the fields of genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; suture materials; massage apparatus; surgical apparatus and instruments; diagnostic apparatus for medical purposes for use in the fields of genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; apparatus for DNA and RNA testing for medical purposes; apparatus for the regeneration of stem cells for medical purposes; syringes for medical purposes; syringes for injections; needles for medical purposes | ACTIVE | — |
| 035 | Advertising services; business management; business administration; providing office functions; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; market research studies; import-export agency services; provision of an on-line marketplace for buyers and sellers of goods and services; office functions in the nature of searching for data in computer files for others | ACTIVE | — |
| 036 | Actuarial services; providing financial information via a website; financial research and information services; financial management; insurance services, namely, underwriting and brokerage of health, medical, and life insurance; insurance brokerage; health insurance underwriting; providing rebates at participating establishments of others through use of a membership card; health insurance information and consultancy services; real estate services, namely, real estate management and investment services; financial affairs and monetary affairs, namely, financial information, management and analysis services; financial consultancy services; capital investment services; financial customs brokerage services; financial evaluations for insurance purposes; investment of funds; issuance of tokens of value; fiscal valuation; charitable fundraising; charitable foundation services, namely, providing fundraising activities, supplemental funding, capital improvement funding, scholarships, and financial assistance for programs and services of others and providing financial support to patients and families for obtaining medications, medical services, medical equipment, and assistive technology; financial sponsorship of patients and families for payment of healthcare, medical, and insurance bills; financial sponsorship of scientific, medical, and drug research and development; financial sponsorship of projects promoting awareness and knowledge of diseases and healthcare issues and facilitating patient, doctor, and healthcare networks | ACTIVE | — |
| 041 | Education, namely, providing of training in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; entertainment services in the nature of arranging social entertainment events; organizing community sporting and cultural activities; coaching and training in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; providing instruction services in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; arranging and conducting of educational conferences in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; arranging and conducting of educational colloquiums in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; arranging and conducting of educational seminars in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; arranging and conducting of educational symposiums in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; arranging and conducting of in-person educational forums in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; publication of texts, other than publicity texts; providing online electronic publications, not downloadable, namely, online non-downloadable electronic publications in the nature of reports, journals, brochures, informational sheets, data sheets, case studies, articles, newsletters, stories, blogs, infographics, images, audio and video recordings, tables, forums, databases, posts, reviews, commentaries, opinions, and statements in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; providing online videos, not downloadable, namely, providing online non-downloadable videos in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; electronic desktop publishing; arranging and conducting of in-person educational forums in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; mobile library services and bookmobile services; online publication of electronic books and journals; publication of books; arranging and conducting of workshops in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine; vocational guidance in the fields of healthcare, scientific and medical research and development, genetically based diseases, rare diseases, ocular diseases, neurological disorders, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, and personalized medicine | ACTIVE | — |
| 042 | Design and development of computer hardware and software; research and development of orphan drugs, stem cell technology, gene therapy, cell therapy, regenerative medicine, personalized medicine and precision medicine | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; agricultural services, namely, compost spreading; forestry services, namely, insecticide spraying for forestry; health and medical counselling; providing health care and medical information; providing a website featuring educational information regarding genetically based diseases, rare diseases, ocular diseases, orphan drugs, gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine, and other treatment options; personal and social services rendered by others to meet the needs of individuals, namely, providing patient advisory and information services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; health care advisory and information services for patients and their families regarding the coordination of medical services; health care advice and consultation services, namely, providing advice, information and assistance to patients and their families in dealing with medical issues relating to medical service providers, hospitals, insurance companies, and others involved in patient care; blood banks and human tissue bank services; providing educational information regarding genetically based diseases, rare diseases, ocular diseases, orphan drugs, gene therapy, cell therapy, precision medicine, regenerative medicine, personalized medicine and other treatment options | ACTIVE | — |
| 045 | Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advocacy services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; providing patient advocacy services in the fields of genetically based diseases, rare diseases, ocular diseases, gene therapy, cell therapy, regenerative medicine, personalized medicine, and precision medicine; providing case management services, namely, coordinating patient and family health care medical services; health care advocacy services for patients and their families regarding the coordination of medical services; health care case management services, namely, medical care coordination for patients and families | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
- Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
- Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named REFLECTIONBIO -BY PATIENTS, FOR PATIENTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 16, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 23, 2023 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jan 20, 2023 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jan 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 8, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 8, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jun 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 8, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 12, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jul 22, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 14, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 17, 2021 | NWAP | NEW APPLICATION ENTERED | — |